Acute myocardial infarction and kidney transplantation

被引:138
作者
Kasiske, Bertram L.
Maclean, J. Ross
Snyder, Jon J.
机构
[1] Univ Minnesota, Dept Med, Coll Med, Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
[2] Minneapolis Med Res Fdn Inc, Chron Dis Res Grp, Minneapolis, MN USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 03期
关键词
D O I
10.1681/ASN.2005090984
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Although the risk for acute myocardial infarction (AMI) is lower after transplantation than on the waiting list, this risk may vary by patient population and may be different early versus late after transplantation. Risk factors for AMI were examined among 53,297 Medicare beneficiaries who were placed on the deceased-donor waiting list in 1995 to 2002. Early (<= 3 mo) and late (> 3 mo) effects of receiving a deceased- or living-donor kidney transplant were examined using time-dependent covariates in Cox nonproportional hazards analysis. Overall, transplantation was associated with a 17% lower adjusted risk for AMI (0.83; 95% confidence interval [CI] 0.77 to 0.90) versus the waiting list. However, the relative risk (versus the waiting list) for AMI was greater for deceased- compared to living-donor transplants, with both being much greater early (deceased-donor 3.57 [95% CI 3.21 to 3.96] compared to living-donor 2.81 [95% CI 2.31 to 3.421) than late (deceased-donor 0.45 [95% CI 0.41 to 0.501 compared to living-donor 0.39 [95% CI 0.33 to 0.47]) posttransplantation. Individuals who were >= 65 yr of age had a much higher risk (versus 18- to 34-yr-olds) for AMI early posttransplantation (8.01; 95% CI 5.12 to 12.53) compared with the waiting list (3.68; 95% CI 3.98 to 4.54) or late posttransplantation (4.37; 95% CI 3.07 to 6.20). Black patients had less reduction in AMI risk (versus white patients) late posttransplantation (0.78; 95% CI 0.64 to 0.95) compared with early posttransplantation (0.60; 95% CI 0.48 to 0.74) or on the waiting list (0.62; 95% CI 0.56 to 0.68). The AMI risk that was associated with chronic kidney disease from diabetes (versus glomerulonephritis) was relatively greater on the waiting list (1.64; 95% CI 1.45 to 1.85) compared with early (1.34; 95% CI 1.08 to 1.68) and late (1.39; 95% CI 1.12 to 1.72) posttransplantation. Thus the risk reduction for AMI with transplantation versus the waiting list varies by patient population and time after transplantation.
引用
收藏
页码:900 / 907
页数:8
相关论文
共 22 条
[1]   Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression [J].
Abbott, KC ;
Yuan, CM ;
Taylor, AJ ;
Cruess, DF ;
Agodoa, LYC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (09) :2358-2365
[2]   Influence of race on kidney transplant outcomes within and outside the department of veterans affairs [J].
Chakkera, HA ;
O'Hare, AM ;
Johansen, KL ;
Hynes, D ;
Stroupe, K ;
Colin, PM ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (01) :269-277
[3]  
Chertow G M, 1997, Adv Ren Replace Ther, V4, P40
[4]   RACIAL-DIFFERENCES IN RENAL-ALLOGRAFT SURVIVAL - THE ROLE OF SYSTEMIC HYPERTENSION [J].
COSIO, FG ;
DILLON, JJ ;
FALKENHAIN, ME ;
TESI, RJ ;
HENRY, ML ;
ELKHAMMAS, EA ;
DAVIES, EA ;
BUMGARDNER, GL ;
FERGUSON, RM .
KIDNEY INTERNATIONAL, 1995, 47 (04) :1136-1141
[5]   Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation [J].
Fellström, B ;
Jardine, AG ;
Soveri, I ;
Cole, E ;
Neumayer, HH ;
Maes, B ;
Gimpelewicz, C ;
Holdaas, H .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (08) :1986-1991
[6]   IMPROVED SURVIVAL OF PRIMARY CADAVERIC RENAL-ALLOGRAFTS IN BLACKS WITH QUADRUPLE IMMUNOSUPPRESSION [J].
GASTON, RS ;
HUDSON, SL ;
DEIERHOI, MH ;
BARBER, WH ;
LASKOW, DA ;
JULIAN, BA ;
CURTIS, JJ ;
BARGER, BO ;
SHROYER, TW ;
DIETHELM, AG .
TRANSPLANTATION, 1992, 53 (01) :103-109
[7]   Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation [J].
Gill, JS ;
Ma, I ;
Landsberg, D ;
Johnson, N ;
Levin, A .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (03) :808-816
[8]   Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial [J].
Holdaas, H ;
Fellström, B ;
Jardine, AG ;
Holme, I ;
Nyberg, G ;
Fauchald, P ;
Grönhagen-Riska, C ;
Madsen, S ;
Neumayer, HH ;
Cole, E ;
Maes, B ;
Ambühl, P ;
Olsson, AG ;
Hartmann, A ;
Solbu, DO ;
Pedersen, TR .
LANCET, 2003, 361 (9374) :2024-2031
[9]   Acute coronary syndromes after renal transplantation in patients with end-stage renal disease resulting from diabetes [J].
Hypolite, IO ;
Bucci, J ;
Hshieh, P ;
Cruess, D ;
Agodoa, LYC ;
Yuan, CM ;
Taylor, AJ ;
Abbott, KC .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (03) :274-281
[10]   Diabetes mellitus after kidney transplantation in the United States [J].
Kasiske, BL ;
Snyder, JJ ;
Gilbertson, D ;
Matas, AJ .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (02) :178-185